about
Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysisGene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysisThe safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewHome telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluationPre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluationSexual health risk reduction interventions for people with severe mental illness: a systematic review.Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UKA cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UKEstimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using dataDiagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.The use of rapid review methods in health technology assessments: 3 case studiesEconomics of tandem mass spectrometry screening of neonatal inherited disorders.A systematic review and economic evaluation of statins for the prevention of coronary events.Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials.Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model.Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation.Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.Management of isolated minor head injury in the UK.Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.Clinical decision rules for children with minor head injury: a systematic review.Diagnostic accuracy of clinical characteristics for identifying CT abnormality after minor brain injury: a systematic review and meta-analysis.Clinical decision rules for adults with minor head injury: a systematic review.Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis.The effectiveness of sexual health interventions for people with severe mental illness: a systematic review.Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?The cost-effectiveness of diagnostic management strategies for children with minor head injury.The cost-effectiveness of diagnostic management strategies for adults with minor head injury.Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
P50
Q26995651-8FBB4760-2E7B-43EB-B1B0-57B3F898F6CBQ27009270-54922456-9EF2-48C5-B15A-5F511DC1DE15Q27013836-0FEFB4FA-6062-4A1F-B71B-8FE4CF01A5C7Q27015006-5F9BA335-49CB-4FEE-9419-F49F1E03D559Q27022399-C13ADE30-132C-4C7D-A8B3-811D33DFE215Q28082492-D3E09395-8F0E-4723-801E-5B8432EE1125Q28175107-E40B81B3-E5F9-4074-888A-9BFD730882DDQ28184375-7E264043-A686-4DFA-9CAF-D50043B97D64Q33370730-89574A9D-93F6-41F4-B78C-13008C997132Q33977765-F4FED0BC-AC2E-4482-8377-220BE79D71FDQ35675003-90B4BD88-4E4A-493F-B061-92ECFE1346C2Q36113531-40B0E2CE-8A65-4013-81EE-B1EC29310A73Q36597613-A777B62A-3C41-4446-A50B-68D45796B851Q36780210-AB6EBFCC-A161-4FAD-BC73-586EE4451E6BQ37190260-B03AD18D-762A-4651-93C3-98D5B7ED754BQ37367505-C3E7F289-1483-4C4F-9D5F-04FA5AE818C9Q37374293-4A6EE993-150E-46BE-92FB-6322A32C4767Q37552113-EACDC738-1425-48ED-B316-75034FE7D1B4Q37611803-0DF4360D-E380-4D92-9AE1-8222EC2C98D5Q37619020-57BEC96F-B888-414D-B5C4-55CFAF7B49A6Q37762631-AF909E40-7C3C-4FAF-B834-51209857DCB5Q37806803-801C9874-0283-4E90-9359-FB396B5AAD00Q37820652-D04A8BB4-D7B1-4820-8460-6553EFCD0BF5Q37839528-33ADA2A6-56CE-4218-B311-8A9832373928Q37909444-0F6A2691-073E-47AE-971E-94617C69F73BQ37911937-1DFB23B2-7E42-421E-BA29-22824CDC86A9Q38051449-979FB15B-3421-4051-A095-CF2695175489Q38107366-46A66214-B24C-4C2E-842F-ED0EA3383AF5Q38177004-B64989A1-7B24-4BE8-9A2F-3418316D194EQ38410380-0DE10F2A-A862-47B1-8D73-417A8496D5B2Q38645144-1B947DFA-7E1D-4524-8823-20ACBA51A366Q38675158-5038F015-6F13-461B-B8F7-4886DD4E26BEQ38988044-8A88F28B-CF4C-40F0-ACE5-9A9B48EDB7A3Q44623106-C8F1CB50-8073-4C4D-B79E-18B4A101489BQ45253941-E74CB095-D633-42C8-A85C-D519F3C88370Q45324181-00A0511E-58BF-4079-88C9-5108590D3142Q46949753-11E21D0A-FB3F-46A6-9516-5658D2891DECQ48952520-85908EB2-7EF1-490D-81C1-3B0AA1B61608Q53273373-D78EA1B1-751A-4BCD-A631-CA56A1BDA488Q53841256-F9B6A52F-ECEB-421F-AC85-43CF074E1D97
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A Pandor
@nl
A Pandor
@sl
Abdullah Pandor
@ca
Abdullah Pandor
@en
Abdullah Pandor
@es
Abdullah Pandor
@pt
type
label
A Pandor
@nl
A Pandor
@sl
Abdullah Pandor
@ca
Abdullah Pandor
@en
Abdullah Pandor
@es
Abdullah Pandor
@pt
altLabel
A Pandor
@en
A. Pandor
@en
prefLabel
A Pandor
@nl
A Pandor
@sl
Abdullah Pandor
@ca
Abdullah Pandor
@en
Abdullah Pandor
@es
Abdullah Pandor
@pt
P1053
E-4643-2010
P106
P21
P31
P3829
P496
0000-0003-2552-5260